Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Reliable detection of heart disease and allergies

02.06.2008
The synlab medical laboratory in Nuremberg is the 5000th customer to purchase the Immulite 2000 Analyzer from Siemens

synlab Nuremberg has put the five thousandth Immulite 2000 Analyzer sold by Siemens worldwide into operation. Franconia's largest laboratory center serves some 1,000 physicians and nine clinics in the region. synlab will primarily use the Immulite 2000 Diagnostic System to test blood and serum samples for heart disease and allergies.


"With the Immulite 2000 from Siemens, we now have one of the most efficient immunoassay analyzers currently on the market", said Alexander Hoffmann, CEO of MVZ synlab Nuremberg. "What I especially appreciate about this device is its outstanding sensitivity and the fact that all process steps from pipetting, incubation, reading the sample and evaluation are fully automated. The personnel capacity required to process samples is thus lower than before."

"We are pleased that we were able to extend our cooperation with synlab. We are convinced that, with their wide spectrum of parameters, our immunoassay systems will make an important contribution to improving health", said Stefan Wolf, Regional Vice President EMEA I und General Manager of Siemens Healthcare Diagnostics in Germany. "Believe it or not, 70 percent of all clinical decisions made by physicians are based on the results of in vitro examinations, however, only two percent of all health-related expenditures are invested in this area. That clearly underscores the benefits that laboratory diagnostics yield for healthcare!" Siemens is the global market leader in immunoassay systems.

Siemens analytical systems contribute to the improvement of healthcare throughout the world and help to detect diseases in an early stage as well as to monitor the course of diseases. The Immulite 2000 is an analytical system for medical diagnostic laboratories that can be used to perform automated tests. This device is one of the most versatile immunoassay systems available on the international laboratory diagnostics market. For example, it can be used to test 450 different allergens. One of its special features is an innvotive patient test for diagnosing sepsis and cardiological diseases. This device has been on the market since 1998, and is now in operation in almost 200 countries worldwide.

synlab Nuremberg offers the entire spectrum of modern laboratory medicine to the physicians of Central Franconia. The focus is on STD diagnostics and gynecological endocrinology. Sample pick-up and report transfer services tailored to the needs of customer practices are understood as the basis for synlab laboratory services. Support of the Central Franconian regional company is provided at Fuerther Strasse 212; some 80 qualified medical employees are employed at Rohrmannstr. 12.

Siemens Healthcare is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first fully integrated diagnostics company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care – from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion.

Marion Bludszuweit | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare
http://www.synlab.de

More articles from Medical Engineering:

nachricht Novel PET imaging agent could help guide therapy for brain diseases
03.04.2018 | Society of Nuclear Medicine and Molecular Imaging

nachricht New Computer Architecture: Time Lapse for Dementia Research
29.03.2018 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>